Nordhealth AS

Mandatory Notification of Trade by Primary Insider in connection with conversion of shares

Helsinki, Finland, 16 December 2025: Oy Pasanen & Co, a close associate of

Valter Pasanen, a primary insider of Nordhealth AS (the "Company"), has today

converted 402,796 Class B shares in the Company to Class A shares.

Following registration of the conversion, the Company has a share capital of NOK

80,191,746, divided into 45,594,543 Class A shares and 34,597,203 Class B

shares, each with nominal value of NOK 1.00. Each Class A share carries one vote

and each Class B share carries 10 votes.

Please refer to the attached notification of trading for further details.

For further information, please contact:

Charles MacBain, CEO [email protected]

Alexander Cram, CFO [email protected]

This information is subject to disclosure requirements set out in the Market

Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act

Section 5-12.

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS

company on a mission to redefine digital healthcare. We build software that

empower veterinary and therapy professionals to provide the best possible care

experiences to their patients. Our products serve more than 60,000 veterinary

and therapy professionals across 13,000 clinics and hospitals located in over 30

countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the

Nordic region and a growing presence internationally, with 400 employees working

either remotely or from offices (collaboration hubs). Visit the company's

website at nordhealth.com (http://www.nordhealth.com).

AI Terminal